EMAIL DETAILS
SUBJECT:
Fwd: MedTag
PRI: NORMAL
FROM:
D
darcher@rosemontcapital.com
DATE:
2015-07-07 19:56:54
MSG_ID:
<CD67A803-D401-4C3F-8376-0F2EB8FE2BB1@rosemontcapital.com>
RECIPIENTS:
TO:
M
Marc L. Holtzman
<marc@marcholtzman.com>
CC:
H
Hunter Biden
<hbiden@rosemontseneca.com>
CONTENT:
TEXT: YES |
HTML: YES
PROCESSED
Marc, In addition to Burisma; see below a high level summary of the progress we've made with an exciting initiative we've been discussing in KZ. Your counsel on moving this as well very much appreciated! Best, Devon Devon D. Archer 646 436 3745 Begin forwarded message: From: Eric Schwerin <eschwerin@rosemontseneca.com<mailto:eschwerin@rosemontseneca.com>> Date: July 7, 2015 at 1:46:17 PM EDT To: Devon Archer <darcher@rosemontcapital.com<mailto:darcher@rosemontcapital.com>> Cc: Hunter Biden <hbiden@rosemontseneca.com<mailto:hbiden@rosemontseneca.com>> Subject: MedTag Hunter asked me to email you the latest on MedTag and what needs to happen next. Background: A couple of months ago, at the direction of the Embassy, we forwarded MedTag’s proposal on to the President of Nazarbayev University. The feedback we got from the Embassy was that they already had a supplier for simulated medical dummies and MedTag’s was much more expensive and they weren’t interested. Unfortunately, they didn’t understand that MedTag’s technology is light years ahead of the typical sim-man or sim-baby and in fact totally different. In addition, MedTag’s proposal offered up a full suite of products NU could purchase which made the price tag seem high. They are happy to start small and expand on their offering over time if NU likes what they see. Next Steps: MedTag believes that the best way to close the sale is for a decision maker from NU to come to Rome and see the breadth of MedTag’s technology and its hospital of the future. While MedTag is happy to go to Astana first it would really move the conversations along quickly if someone from NU were to come to Rome. But first, the Kazakhs need to identify someone who is a decision maker at NU that MedTag can begin conversations with. At my last meeting at the Embassy, it was suggested that it should be one of the Vice Deans of the Medical School (mostly because he would be in DC in July), but our impression is that this person may be too low on the decision making hierarchy. FYI, the Dean of the Medical School, Massimo Pignatelli, is Italian and would seem like a natural ally. Also, keep in mind, MedTag is a subsidiary of the TAG group - makers of Tag Heuer and also a subsidiary of the McLaren Group (of automobile fame). They have an extremely reputable pedigree. Eric D. Schwerin Rosemont Seneca Partners, LLC 1010 Wisconsin Ave., NW Suite 705 Washington, DC 20007 (202) 333-1880 eschwerin@rosemontseneca.com<x-msg://59/eschwerin@obblaw.com> P Consider the environment before printing this email.
METADATA:
THREAD:
TOPIC:
MedTag
INDEX:
AQHQuNzVVvgIwk0eCkaRVNJohtFn9p3QbGux
REFERENCES:
REPLY_TO:
<FB9DCCBF-9FAD-4603-9C89-5D8BDBF9DF9A@rosemontseneca.com>
REFS:
<FB9DCCBF-9FAD-4603-9C89-5D8BDBF9DF9A@rosemontseneca.com>